Predictors of early mortality in veteran patients with pancreatic cancer.

[1]  Douglas B. Evans,et al.  Prognostic factors in patients with unresectable locally advanced pancreatic adenocarcinoma treated with chemoradiation , 2006, Cancer.

[2]  T. Ertan,et al.  Value of preoperative serum CA 19-9 levels in predicting resectability for pancreatic cancer. , 2006, Canadian journal of surgery. Journal canadien de chirurgie.

[3]  A. Jemal,et al.  Cancer Statistics, 2006 , 2006, CA: a cancer journal for clinicians.

[4]  I. Schmid,et al.  Effects of soluble TNF receptor II (sTNF-RII), IL-1 receptor antagonist (IL-1ra), tumor load and hypermetabolism on malnutrition in children with acute leukemia. , 2005, European journal of medical research.

[5]  F. Gansauge,et al.  Treatment of Pancreatic Cancer: Challenge of the Facts , 2003, World Journal of Surgery.

[6]  R. Parks,et al.  Prognostic factors in the palliation of pancreatic cancer. , 2003, European journal of surgical oncology : the journal of the European Society of Surgical Oncology and the British Association of Surgical Oncology.

[7]  C. McArdle,et al.  Albumin Concentrations Are Primarily Determined by the Body Cell Mass and the Systemic Inflammatory Response in Cancer Patients With Weight Loss , 2001, Nutrition and cancer.

[8]  H. Ueno,et al.  Prognostic Factors in Patients with Metastatic Pancreatic Adenocarcinoma Receiving Systemic Chemotherapy , 2000, Oncology.

[9]  D. Gouma,et al.  Pooling of prognostic studies in cancer of the pancreatic head and periampullary region: the Triple-P study. Triple-P study group. , 2000, The European journal of surgery = Acta chirurgica.

[10]  A. Vigano,et al.  Clinical survival predictors in patients with advanced cancer. , 2000, Archives of internal medicine.

[11]  K. Lillemoe,et al.  Is prophylactic gastrojejunostomy indicated for unresectable periampullary cancer? A prospective randomized trial. , 1999, Annals of surgery.

[12]  J. Cubiella,et al.  Prognostic factors in nonresectable pancreatic adenocarcinoma: a rationale to design therapeutic trials , 1999, American Journal of Gastroenterology.

[13]  C. Su,et al.  Diagnostic and prognostic values of CA 19-9 and CEA in periampullary cancers. , 1999, Journal of the American College of Surgeons.

[14]  T. Ponchon,et al.  Predictive factors for survival of patients with inoperable malignant distal biliary strictures: a practical management guideline , 1998, Gut.

[15]  J. Ross,et al.  Acute‐phase protein response and survival duration of patients with pancreatic cancer , 1995, Cancer.

[16]  D. Bajorin,et al.  Prognostic factors in patients with metastatic malignant melanoma: A multivariate analysis , 1993, Cancer.

[17]  T. Nishimura,et al.  Indentificattion of Colony-stimulating Factor Activity in Patients with Malignant Tumors Associated with Excessive Leukocytois , 1991 .

[18]  M. Izuo,et al.  [Colony stimulating factor producing carcinoma of the pancreas--a case report]. , 1989, Gan no rinsho. Japan journal of cancer clinics.

[19]  J. Zech,et al.  [Prognostically relevant factors in ductal pancreatic cancer]. , 1989, Der Chirurg; Zeitschrift fur alle Gebiete der operativen Medizen.

[20]  Y. Ku,et al.  Predicting factors for survival of patients with unresectable pancreatic cancer: a management guideline. , 2003, Hepato-gastroenterology.

[21]  W. Henderson,et al.  Preoperative serum albumin level as a predictor of operative mortality and morbidity: results from the National VA Surgical Risk Study. , 1999, Archives of surgery.